CLINICAL-PHARMACOLOGY OF 4-DEMETHOXYDAUNORUBICIN (DMDR)

被引：33

作者：

LU, K ^{[1
]}

SAVARAJ, N ^{[1
]}

KAVANAGH, J ^{[1
]}

FEUN, LG ^{[1
]}

BURGESS, M ^{[1
]}

BODEY, GP ^{[1
]}

LOO, TL ^{[1
]}

机构：

[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DIV MED,6723 BERTNER AVE,HOUSTON,TX 77030

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1986年 / 17卷 / 02期

关键词：

D O I：

10.1007/BF00306743

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：143 / 148

页数：6

共 12 条

[1]

ARACAMONE F, 1976, CANCER TREAT REP, V60, P829

[2]

BENJAMIN RS, 1973, CLIN PHARMACOL THER, V14, P592

[3]

BERMAN E, 1983, CANCER RES, V43, P6096

[4] ANTI-LEUKEMIC ACTIVITY OF 4-DEMETHOXYDAUNORUBICIN IN MICE [J].

CASAZZA, AM ;

PRATESI, G ;

GIULIANI, F ;

DIMARCO, A .

TUMORI, 1980, 66 (05) :549-564

[5]

CASAZZA AM, 1979, P AM ASSOC CANC RES, V20, P16

[6]

CASAZZA AM, 1979, CANCER TREAT REP, V63, P835

[7]

CASAZZA AM, 1979, ANTHRACYCLINES CURRE, P403

[8]

DAGHESTANI AN, 1985, CANCER RES, V45, P1408

[9]

Di Marco A, 1978, Antibiot Chemother (1971), V23, P12

[10]

PACCIARINI MA, 1982, 13TH P INT CANC C

← 1 2 →